Gross Profit - Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 5.4 USD 3.85%

Updated:

Aurinia Pharmaceuticals Inc
Gross Profit

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Aurinia Pharmaceuticals Inc
Gross Profit Peer Comparison

ZYME

TH

RPTX

FUSN

EDT

Company		Gross Profit	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Gross Profit $169.9m	CAGR 3-Years 480%	CAGR 5-Years N/A	CAGR 10-Years 68%
	Zymeworks Inc NYSE:ZYME	Gross Profit N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Theratechnologies Inc TSX:TH	Gross Profit $57.9m	CAGR 3-Years 14%	CAGR 5-Years 11%	CAGR 10-Years 36%
	Repare Therapeutics Inc NASDAQ:RPTX	Gross Profit N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Fusion Pharmaceuticals Inc NASDAQ:FUSN	Gross Profit N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Spectral Medical Inc TSX:EDT	Gross Profit CA$662k	CAGR 3-Years -23%	CAGR 5-Years -28%	CAGR 10-Years -10%

See Also

Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Gross Profit amounts to 169.9m USD.

Over the last year, the Gross Profit growth was 21%. The average annual Gross Profit growth rates for Aurinia Pharmaceuticals Inc have been 480% over the past three years , and 68% over the past ten years .

Join more than 137,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.